Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin + Chemotherapy in Advanced Ovarian, Fallopian Tube and Primary Peritoneal Cancer
NCT02122185Phase 2Completed
- Sponsor
- University of Chicago
- Start
- Feb 2015
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liquid metformin (Aspargo Labs) in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by University of Chicago. Started Feb 2015; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT02122185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02122185.